{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:11:24Z","timestamp":1778944284715,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","award":["FFC 2020"],"award-info":[{"award-number":["FFC 2020"]}],"id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bone.2024.117316","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T13:43:20Z","timestamp":1730555000000},"page":"117316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Teriparatide administration is osteoanabolic but does not impact atherosclerotic plaque calcification and progression in a mouse model of menopause"],"prefix":"10.1016","volume":"190","author":[{"given":"Laurence","family":"Bessueille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Briolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00efda","family":"Mebarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Viallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Magne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9003","key":"10.1016\/j.bone.2024.117316_bb0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(96)90075-6","article-title":"Age at menopause as a risk factor for cardiovascular mortality","volume":"347","author":"van der Schouw","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bone.2024.117316_bb0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2015.01.017","article-title":"Sex differences in coronary artery disease: pathological observations","volume":"239","author":"Yahagi","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bone.2024.117316_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2020.01.023","article-title":"Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression","volume":"297","author":"Schreinlechner","year":"2020","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.bone.2024.117316_bb0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCRESAHA.116.307971","article-title":"Noninvasive molecular imaging of disease activity in atherosclerosis","volume":"119","author":"Dweck","year":"2016","journal-title":"Circ. Res."},{"issue":"26","key":"10.1016\/j.bone.2024.117316_bb0025","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1073\/pnas.1308814110","article-title":"Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries","volume":"110","author":"Kelly-Arnold","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.bone.2024.117316_bb0030","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.RES.0000171451.88616.c2","article-title":"Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?","volume":"96","author":"Nadra","year":"2005","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bone.2024.117316_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcmg.2017.10.012","article-title":"Coronary artery calcification and its progression: what does it really mean?","volume":"11","author":"Mori","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.bone.2024.117316_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcmg.2020.08.036","article-title":"The relationship between coronary calcification and the natural history of coronary artery disease","volume":"14","author":"Jin","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"2","key":"10.1016\/j.bone.2024.117316_bb0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.291.2.210","article-title":"Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals","volume":"291","author":"Greenland","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2024.117316_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.622736","article-title":"The elusive origin of atherosclerotic plaque calcification","volume":"9","author":"Canet-Soulas","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.bone.2024.117316_bb0055","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/01.ATV.0000166600.58468.1b","article-title":"Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells","volume":"25","author":"Rattazzi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bone.2024.117316_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191976","article-title":"Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification","volume":"13","author":"Espitia","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bone.2024.117316_bb0065","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/jbmr.3830","article-title":"Association between abdominal aortic calcification, bone mineral density, and fracture in older women","volume":"34","author":"Lewis","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2024.117316_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-006-0282-z","article-title":"Vascular calcification and osteoporosis\u2014from clinical observation towards molecular understanding","volume":"18","author":"Hofbauer","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117316_bb0075","first-page":"47","article-title":"Vascular effects of bisphosphonates-a systematic review, Clin Med Insights Endocrinol","volume":"5","author":"Santos","year":"2012","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.bone.2024.117316_bb0080","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.05.050","article-title":"Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (The Multi-Ethnic Study of Atherosclerosis)","volume":"56","author":"Elmariah","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.bone.2024.117316_bb0085","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jbmr.2043","article-title":"RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk","volume":"29","author":"Samelson","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"18","key":"10.1016\/j.bone.2024.117316_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032571","article-title":"Effect of denosumab or alendronate on vascular calcification: secondary analysis of SALTIRE2 randomized controlled trial","volume":"13","author":"Geers","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"25","key":"10.1016\/j.bone.2024.117316_bb0095","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/CIRCULATIONAHA.121.054823","article-title":"Hearts of stone: calcific aortic stenosis and antiresorptive agents for osteoporosis","volume":"143","author":"Demer","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bone.2024.117316_bb0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study","volume":"7","author":"McClung","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"16","key":"10.1016\/j.bone.2024.117316_bb0105","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bone.2024.117316_bb0110","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bone.2024.117316_bb0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/ATVBAHA.119.312371","article-title":"Cardiovascular outcomes of romosozumab and protective role of alendronate","volume":"39","author":"Asadipooya","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.bone.2024.117316_bb0120","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/14740338.2022.2160445","article-title":"What is the risk of cardiovascular events in osteoporotic patients treated with romosozumab?","volume":"21","author":"Reid","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bone.2024.117316_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jot.2024.07.011","article-title":"Treatment effects, adverse outcomes and cardiovascular safety of romosozumab - existing worldwide data: a systematic review and meta-analysis","volume":"48","author":"Wong","year":"2024","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.bone.2024.117316_bb0130","article-title":"Cardiovascular safety of romosozumab compared to commonly used anti-osteoporosis medications in postmenopausal osteoporosis: a systematic review and network meta-analysis of randomized controlled trials","author":"Cheng","year":"2024","journal-title":"Drug Saf."},{"issue":"7","key":"10.1016\/j.bone.2024.117316_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071403","article-title":"Review of current real-world experience with teriparatide as treatment of osteoporosis in different patient groups","volume":"10","author":"Hauser","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bone.2024.117316_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11657-019-0672-4","article-title":"No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis","volume":"15","author":"Ferrieres","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2024.117316_bb0145","article-title":"Cardiac adverse events in bisphosphonate and teriparatide users: an international pharmacovigilance study","volume":"168","author":"Rodr\u00edguez","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117316_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-024-07255-6","article-title":"Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study","author":"Masuda","year":"2024","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2024.117316_bb0155","article-title":"The effectiveness and safety of romosozumab and teriparatide in postmenopausal women with osteoporosis","author":"Hartz","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2024.117316_bb0160","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae348","article-title":"Cardiovascular safety of romosozumab vs. PTH analogs for osteoporosis treatment: a propensity score matched cohort study","author":"Stokar","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"50","key":"10.1016\/j.bone.2024.117316_bb0165","doi-asserted-by":"crossref","first-page":"50195","DOI":"10.1074\/jbc.M308825200","article-title":"Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice","volume":"278","author":"Shao","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bone.2024.117316_bb0170","doi-asserted-by":"crossref","first-page":"H1203","DOI":"10.1152\/ajpheart.00718.2017","article-title":"Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice","volume":"314","author":"Hsu","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.bone.2024.117316_bb0175","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/GME.0000000000000328","article-title":"Impact of estrogens on atherosclerosis and bone in the apolipoprotein E-deficient mouse model","volume":"22","author":"Fern\u00e1ndez-Murga","year":"2015","journal-title":"Menopause"},{"issue":"19","key":"10.1016\/j.bone.2024.117316_bb0180","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1073\/pnas.93.19.10022","article-title":"Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"93","author":"Bourassa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bone.2024.117316_bb0185","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCRESAHA.110.216846","article-title":"Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification","volume":"107","author":"Osako","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bone.2024.117316_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","article-title":"Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts","volume":"6","author":"Han","year":"2018","journal-title":"Bone Res"},{"issue":"10","key":"10.1016\/j.bone.2024.117316_bb0195","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1210\/en.2019-00239","article-title":"Teriparatide improves bone and lipid metabolism in a male rat model of type 2 diabetes mellitus","volume":"160","author":"Nomura","year":"2019","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bone.2024.117316_bb0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/cen.13139","article-title":"Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis","volume":"85","author":"Celer","year":"2016","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2024.117316_bb0205","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.STR.0000078371.00577.76","article-title":"Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis","volume":"34","author":"Mart\u00edn-Ventura","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.bone.2024.117316_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-62703-562-0_6","article-title":"A method for direct assessment of tissue-nonspecific alkaline phosphatase (TNAP) inhibitors in blood samples","volume":"1053","author":"Sergienko","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bone.2024.117316_bb0215","first-page":"2","article-title":"Inhibition of alkaline phosphatase impairs dyslipidemia and protects mice from atherosclerosis","author":"Bessueille","year":"2022","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.bone.2024.117316_bb0220","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cmet.2015.01.002","article-title":"Genetic architecture of insulin resistance in the mouse","volume":"21","author":"Parks","year":"2015","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bone.2024.117316_bb0225","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2024.117316_bb0230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2024.117316_bb0235","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2012.157","article-title":"The skeleton as an endocrine organ","volume":"8","author":"DiGirolamo","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.bone.2024.117316_bb0240","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bone.2024.117316_bb0245","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCRESAHA.112.267237","article-title":"Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification","volume":"111","author":"Sun","year":"2012","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bone.2024.117316_bb0250","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.4317\/medoral.20412","article-title":"Intermittent administration of parathyroid hormone improves the repairing process of rat calvaria defects: a histomorphometric and radiodensitometric study","volume":"20","author":"Silva","year":"2015","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"issue":"2","key":"10.1016\/j.bone.2024.117316_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2008.04.012","article-title":"Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice","volume":"43","author":"Sugiyama","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2024.117316_bb0260","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s00018-015-1876-4","article-title":"Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes","author":"Bessueille","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bone.2024.117316_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116610","article-title":"Evidence for the cardiovascular effects of osteoporosis treatments in randomized trials of post-menopausal women: a systematic review and Bayesian network meta-analysis","volume":"167","author":"Seeto","year":"2023","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2024.117316_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050996","article-title":"The impact of antiosteoporotic drugs on glucose metabolism and fracture risk in diabetes: good or bad news?","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2024.117316_bb0275","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1194\/jlr.R800070-JLR200","article-title":"Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond","volume":"50","author":"Pendse","year":"2009","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.bone.2024.117316_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008586","article-title":"Osteocalcin is necessary for the alignment of apatite crystallites, but not glucose metabolism, testosterone synthesis, or muscle mass","volume":"16","author":"Moriishi","year":"2020","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.bone.2024.117316_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008361","article-title":"An osteocalcin-deficient mouse strain without endocrine abnormalities","volume":"16","author":"Diegel","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bone.2024.117316_bb0290","article-title":"Serum biomarkers for arterial calcification in humans: a systematic review","volume":"17","author":"Gol\u00fcke","year":"2022","journal-title":"Bone Rep"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224003053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224003053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:16:13Z","timestamp":1778940973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328224003053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":58,"alternative-id":["S8756328224003053"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2024.117316","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teriparatide administration is osteoanabolic but does not impact atherosclerotic plaque calcification and progression in a mouse model of menopause","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2024.117316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117316"}}